In our earlier GLP-1 Insight Drop, we showed how the 2021 approval of Wegovy catalyzed a step-change in metabolic R&Dso much so that GLP-1 programs now account for 159 out of 426 active metabolic programs (~40%), effectively lifting the entire category
Traditional DMARDs, like methotrexate, sulfasalazine, and hydroxychloroquine, suppress the immune system to prevent it from attacking the joints
Treating Obesity May Lower Some Cancer Risks Excess body weight is a known risk factor for several cancers, says Sun Kim, MD, an endocrinologist who specializes in type 2 diabetes, polyendocrine metabolic ovarian syndrome (PMOS), and obesity at Stanford Health in California
Researchers are exploring the potential of sleep peptides to help normalise poor sleep quality and disturbed sleep patterns which may be of therapeutic use for those with chronic insomnia or other sleep disorders
its a direct threat to your public health